The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xing, L.
Right arrow Articles by Remick, D. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xing, L.
Right arrow Articles by Remick, D. G.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CYCLOHEXIMIDE
*DACTINOMYCIN
*DIMETHYL SULFOXIDE
The Journal of Immunology, 2005, 174: 6195-6202.
Copyright © 2005 by The American Association of Immunologists

Mechanisms of Dimethyl Sulfoxide Augmentation of IL-1{beta} Production 1

Liyu Xing and Daniel G. Remick2

Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109-0602

Expression of the inflammatory cytokine IL-1{beta} occurs in various inflammatory diseases, and IL-1{beta} production is regulated at multiple levels. There are conflicting reports about the effects of antioxidants on IL-1{beta} production. In this study, we investigated the regulatory role of the antioxidant DMSO on LPS-stimulated IL-1{beta} gene expression in human PBMC and in vivo. This study demonstrated that 1% DMSO increased LPS-stimulated (50 ng/ml) IL-1{beta} secretion in a dose- and time-dependent manner without altering TNF or IL-6. DMSO also elevated IL-1{beta} secretion by PBMC in response to exogenous superoxide anions. Despite the increase in IL-1{beta}, there was no augmentation of NF-{kappa}B with the addition of DMSO. The steady state mRNA coding for IL-1{beta} following LPS stimulation was also increased. Cycloheximide studies demonstrated that the DMSO augmentation of IL-1{beta} mRNA did not require de novo protein synthesis, and studies with actinomycin D showed that DMSO did not alter the half-life of IL-1{beta} mRNA, suggesting that DMSO did not change the stability of IL-1{beta} mRNA. Experiments using a reporter vector containing the 5'-flanking region of the human IL-1{beta} gene revealed that DMSO augmented LPS-induced IL-1{beta} reporter activity. In vivo, treatment of mice with DMSO significantly increased plasma levels of IL-1{beta} after endotoxin challenge. These data indicate that DMSO directly increases LPS-stimulated IL-1{beta} protein production through the mechanisms of augmenting promoter activity and increasing mRNA levels.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.